Skip to content
Cohealyx Primary Logo (1)
Cohealyx Header 2

Cohealyx Collagen Dermal Matrix is bioengineered for full-thickness wound management. Balanced using proprietary TetraPure™ Technology, it supports cellular infiltration and revascularization.1

Built for speed. Designed for confidence.

TetraPure Technology
Uniquely purified and bioengineered with ideal pore structure for integration into the wound bed and
revascularization.1,2

Close with Confidence
Revascularization
and wound bed readiness evident by day 7 in pre-clinical studies.1

Dependable Performance
Controlled
resorption in the wound bed.3

One-of-a-Kind Portfolio
Cohealyx, RECELL®, and PermeaDerm® are exclusive solutions offered by AVITA Medical.

Balanced Collagen Composition
Purified from young bovine dermis, Cohealyx contains Type I and Type III collagen. Type III collagen is linked to reduced scarring and contraction.4-7

CSA Icons_Group

The Cohealyx Advantage

Cohealyx’s advanced structure promotes cellular migration and revascularization, creating an optimal wound environment.

Request Information

How Cohealyx Works

Day 0 - Cohealyx

Application:
Cohealyx is placed on a cleanly excised wound bed.

Day 3 - Cohealyx

Integration:
Cells migrate into the porous structure and revascularization progresses.

Day 7 - Cohealyx

Ready for Closure:
Cohealyx is integrated into the wound bed, supporting definitive closure management.

Photographs from porcine excision wound model. Animal model results do not necessarily translate to clinical results.

Cohealyx microarchitecture
Cohealyx histology

Histology from porcine excision wound model. Animal model results do not necessarily translate to clinical results.

How Cohealyx Excels

Feature Coheaylx Why It Matters
Collagen type Type I & III from young bovine dermis Type III collagen is linked to reduced scarring and contraction5,6,7
Vascularization time As early as 7 days in pre-clinical studies  Early closure is linked to better patient outcomes8
Resorption Controlled resorption: approx. 30 days1,3 Provides an initial scaffold for cellular ingrowth and revascularization
Flexibility Soft and pliable Easily conforms to the wound bed
Cost effective Economical with simple, flat pricing Expands access to advanced wound management
Thickness 3 mm  Provides volumetric build1

 

Experience Cohealyx in Complex Wound Applications

Full-Thickness

Case Details: 48-year-old-male. Right hand and wrist, 440 cm2.

Cohealyx Full Thickness Post Surgical Excision 2
Cohealyx Full Thickness Application 2
Cohealyx Full Thickness Ready for Closure 2
Cohealyx Full Thickness Post mSTSG 2

Photos Courtesy of John Loftus, MD and Ariel Rodgers, MD (The Ohio State University, Wexner Medical Center).

Surgical Wound

Case Details: 67-year-old-female with DM, previous DFUs and amputations. Left palmar hand, 32 cm2.

Cohealyx Surgical Wound Prior to Surgical Excision 2
Cohealyx Surgical Wound Application 2
Cohealyx Surgical Wound Ready for Closure Management 2
Cohealyx Surgical Wound Day 3 Post mSTSG 2

Photos Courtesy of John Loftus, MD (The Ohio State University, Wexner Medical Center).

Model Description Size (cm) cm2 Units/Box
BDCDM24 Cohealyx™ Collagen Dermal Matrix 2 x 4 8 1
BDCDM55 Cohealyx™ Collagen Dermal Matrix 5 x 5 25 1
BDCDM1010 Cohealyx™ Collagen Dermal Matrix 10 x 10 100 1
BDCDM1020 Cohealyx™ Collagen Dermal Matrix 10 x 20 200 1
BDCDM2035 Cohealyx™ Collagen Dermal Matrix 20 x 35 700 1

 

Experience Cohealyx. Contact us to schedule an evaluation.
Call 833-462-8482 or email us at customerservice@AVITAmedical.com

References:
1. Pre-clinical data on file; publication in progress. 2. Internal data on file: SEM and Porosity Testing; cell assays. 3. Internal data on file: resorption data. 4. Internal data on file: SDS-PAGE Analysis. 5. Ramshaw JA. Connect Tissue Res. 1986;14(4):307-14. 6. Ehrlich HP. Eye (Lond). 1988;2 (Pt 2):149-57. 7. Zoppi N, et. al. J Biol Chem. 2004 Apr 30;279(18):18157-68. 8. Phelan HA, Bernal E. Treatment of deep burn injury. Mar 12, 2024

mSTSG = Meshed Split Thickness Skin Graft and DM = Diabetes Mellitus, DFU = Diabetic Foot Ulcer
 
©2025 AVITA Medical. AVITA Medical®, the AVITA Medical logo, CohealyxTM, the Cohealyx logo, RECELL®, and TetraPureTM Technology are trademarks of AVITA Medical. PERMEADERM is a registered trademark owned by Stedical Scientific, Inc. All other trademarks are the properties of their respective owners. PRO-1952-v1
AVITA_Logo_tag